| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | P30AI168439 | Interdisciplinary NexGen TB research Advancement Center (IN-TRAC) | 000 | 3 | NIH | 10/25/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $28,123,618 ) (Continued on the next page) |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI170197 | Understanding Co-morbidities: COVID-19 in individuals living with HIV/AIDS | 000 | 3 | NIH | 1/31/2024 | $887,719 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI181701 | Modulating Indoleamines to Optimize Immunity in the Setting of Mtb/HIV Co-infection | 001 | 1 | NIH | 9/12/2024 | $91,493 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI181701 | Modulating Indoleamines to Optimize Immunity in the Setting of Mtb/HIV Co-infection | 000 | 1 | NIH | 6/21/2024 | $823,434 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI173245 | M. tuberculosis metabolites to activate human mucosal-associated invariant T cells | 001 | 2 | NIH | 6/26/2024 | $648,933 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | P51OD011133 | The Southwest National Primate Research Center Supplement- Infrastructure improvements of ABSL2 holding areas | 002 | 26 | NIH | 8/30/2024 | $496,000 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | P51OD011133 | The Southwest National Primate Research Center Supplement- Infrastructure improvements of ABSL2 holding areas | 000 | 26 | NIH | 5/2/2024 | $5,986,845 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | P51OD011133 | The Southwest National Primate Research Center Supplement- Infrastructure improvements of ABSL2 holding areas | 001 | 26 | NIH | 5/14/2024 | $1,496,712 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R61AI169026 | Advancing Innovative Next_generation Heterologous Vaccines Against Tuberculosis | 000 | 3 | NIH | 4/12/2024 | $266,414 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R61AI169026 | Advancing Innovative Next_generation Heterologous Vaccines Against Tuberculosis | 000 | 3 | NIH | 4/12/2024 | $266,415 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI184623 | Mechanisms of efficient control of Mycobacterium tuberculosis in the lungs prior to granuloma | 000 | 1 | NIH | 7/9/2024 | $1,091,124 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AG065546 | Microbiome-mediated therapies for aging and healthspan in marmosets | 000 | 5 | NIH | 6/11/2024 | $481,395 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI179465 | Viral and host determinants of donor-specific anti-HIV/SIV immunity mediated by APOBEC3-enzyme | 000 | 1 | NIH | 6/21/2024 | $856,769 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI158963 | Mathematical modeling of Mycobacterium tuberculosis dissemination | 001 | 3 | NIH | 3/13/2024 | $575,582 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI158963 | Mathematical modeling of Mycobacterium tuberculosis dissemination | 002 | 3 | NIH | 5/15/2024 | $58,507 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI158963 | Mathematical modeling of Mycobacterium tuberculosis dissemination | 004 | 3 | NIH | 7/25/2024 | $494,103 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | U42OD010442 | Establishment of a SPF Rhesus Macaque Colony | 001 | 23 | NIH | 5/14/2024 | $483,595 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI179412 | Intrarectal Immunization for a Barrier to Mucosal HIV Infection | 000 | 1 | NIH | 4/19/2024 | $886,165 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI179412 | Intrarectal Immunization for a Barrier to Mucosal HIV Infection | 001 | 1 | NIH | 9/12/2024 | $98,461 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R03AI174973 | Determining the Functional Significance of Mutations Observed in Envelope Protein Following Serial In Vivo Passaging of Human-Simian Immunodeficiency Virus | 000 | 2 | NIH | 7/17/2024 | $99,000 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | U42OD010442 | Establishment of a SPF Rhesus Macaque Colony | 000 | 23 | NIH | 2/15/2024 | $1,934,385 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI157850 | Role of cellular long non-coding RNAs in HIV replication and disease outcome | 000 | 3 | NIH | 7/17/2024 | $495,000 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01DA052845 | Epigenetic mechanisms underlying cannabinoid modulation of neuroinflammation in HIV/SIV infection | 000 | 5 | NIH | 7/8/2024 | $692,889 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R56AI184089 | Effect of IL-21 treatment concurrent to ART and 3HP in Mtb/SIV co-infection | 000 | 1 | NIH | 8/28/2024 | $718,758 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI166049 | Genomic consequences of schistosome hybridization | 000 | 4 | NIH | 8/1/2024 | $613,689 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R25GM142021 | It's Contagious! Promoting the Biomedical Workforce Pipeline through Infectious Diseases | 000 | 3 | NIH | 7/1/2024 | $258,275 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI172539 | Durable HIV Vaccine Targeting Mucosal Epithelium | 001 | 3 | NIH | 8/2/2024 | $970,600 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI184581 | Impact of HIV on the human alveolar environment drivingthe early events of Mycobacterium tuberculosis infection | 000 | 1 | NIH | 8/16/2024 | $1,011,348 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI048071 | Mapping Drug Resistance Genes in Plasmodium falciparum | 001 | 22 | NIH | 5/16/2024 | $90,716 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI172539 | Durable HIV Vaccine Targeting Mucosal Epithelium | 000 | 3 | NIH | 7/9/2024 | $887,962 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI170197 | Understanding Co-morbidities: COVID-19 in individuals living with HIV/AIDS | 001 | 3 | NIH | 5/23/2024 | $98,636 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01MH130193 | Brain myeloid cell-targeted multiplexed gene editing for SIV/HIV eradication | 001 | 3 | NIH | 5/3/2024 | $78,637 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI176309 | Improving rapid phenotypic drug susceptibility testing for drug resistant tuberculosis in high-burden areas | 001 | 2 | NIH | 5/24/2024 | $88,756 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | P30AI168439 | Interdisciplinary NexGen TB research Advancement Center (IN-TRAC) | 001 | 3 | NIH | 4/12/2024 | $114,988 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01MH130193 | Brain myeloid cell-targeted multiplexed gene editing for SIV/HIV eradication | 000 | 3 | NIH | 2/5/2024 | $304,037 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01MH130193 | Brain myeloid cell-targeted multiplexed gene editing for SIV/HIV eradication | 000 | 3 | NIH | 2/5/2024 | $403,691 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R21AI168934 | Novel antiviral strategy offering forward capability and reduced risk of escape | 001 | 2 | NIH | 3/27/2024 | $247,500 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | P30AI168439 | Interdisciplinary NexGen TB research Advancement Center (IN-TRAC) | 000 | 3 | NIH | 2/8/2024 | $1,034,911 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI176309 | Improving rapid phenotypic drug susceptibility testing for drug resistant tuberculosis in high-burden areas | 000 | 2 | NIH | 3/8/2024 | $798,802 |
| | 2024 | 2024 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI048071 | Mapping Drug Resistance Genes in Plasmodium falciparum | 000 | 22 | NIH | 11/21/2023 | $816,445 |
| | 2024 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01HL145411 | Predicting tuberculosis outcomes using genotypic and biomarker signatures | 002 | 5 | NIH | 10/25/2023 | $417,316 |
| | 2024 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | C06OD036038 | Further expansion of the Southwest National Primate Research Center Specific Pathogen Free Rhesus Macaque Resource | 000 | 1 | NIH | 4/11/2024 | $0 |
| | 2024 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | C06OD036038 | Further expansion of the Southwest National Primate Research Center Specific Pathogen Free Rhesus Macaque Resource | 000 | 1 | NIH | 4/11/2024 | $0 |
| | 2024 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | F99AG079802 | Elucidate the adverse impact of mitochondria-induced oxidative stress in molecular and cellular determinants in the aging lung, driving susceptibility to Mycobacterium tuberculosis infection | 000 | 2 | NIH | 3/27/2024 | -$36,974 |
| | 2024 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI134245 | Host-Directed Therapy to Augment anti-M. tuberculosis Responses in the Setting of HIV Co-infection and to Sterilize the Tuberculoma | 000 | 7 | NIH | 3/14/2024 | $0 |
| | 2024 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R21AI168934 | Novel antiviral strategy offering forward capability and reduced risk of escape | 000 | 1 | NIH | 2/21/2024 | $0 |
| | 2024 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01HL145411 | Predicting tuberculosis outcomes using genotypic and biomarker signatures | 000 | 5 | NIH | 10/17/2023 | $0 |
| | 2024 | 2022 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R21AI154336 | Tunneling nanotubes as an alternate route of Ebola virus dissemination | 000 | 2 | NIH | 8/21/2024 | $0 |
|
